(VIANEWS) – Today, the AICapitalize artificial intelligence algorithm suggests a high probability of discovering the approximate price for tomorrow of America Movil AMX, Genmab GMAB and others.
Via News will regularly fact-check this AI algorithm that aims to consistently predict the next session price and next week’s trend of financial assets.
AICapitalize provides A.I.-based statistical tools to help investors make decisions. The table below shows the financial assets predicting price, ordered by the highest expected accuracy.
AICapitalize officials say this tool helps investors make better-informed decisions, supposedly used alongside other relevant financial information and the specific trader strategy.
In the next session, Via News will report the finding on the algorithm precision.
| Financial Asset | Accuracy | Close Price | Prediction |
|---|---|---|---|
| America Movil (AMX) | 98.73% | $19.33 | ⇧ $19.47 |
| Genmab (GMAB) | 98.51% | $29.09 | ⇧ $29.96 |
| Orix Corp (IX) | 94.7% | $104.94 | ⇧ $106.29 |
| argenx SE (ARGX) | 94.57% | $412.51 | ⇧ $415.67 |
| Abbott Laboratories (ABT) | 94.19% | $119.07 | ⇧ $121.65 |
| Toll Brothers (TOL) | 94.14% | $111.38 | ⇧ $114.36 |
| Darden Restaurants (DRI) | 93.75% | $169.8 | ⇧ $173.86 |
| Astrazeneca (AZN) | 93.75% | $66.33 | ⇧ $67.77 |
| Sherwin (SHW) | 93.17% | $327.83 | ⇧ $334.77 |
| Trip.com (TCOM) | 93.06% | $44.22 | ⇧ $45 |
| Marriott International (MAR) | 92.99% | $248.78 | ⇧ $255.1 |
| CRH PLC (CRH) | 92.88% | $78.47 | ⇧ $80.7 |
| Baxter International (BAX) | 89.31% | $41.74 | ⇧ $42.27 |
| eBay (EBAY) | 89.25% | $44.65 | ⇧ $45.7 |
| Citizens Financial Group (CFG) | 89.19% | $30.76 | ⇧ $30.87 |
| Kellogg Company (K) | 89.14% | $55.56 | ⇧ $57.02 |
| Hormel Foods (HRL) | 89.06% | $30.92 | ⇧ $31.85 |
| Air Products and Chemicals (APD) | 89.01% | $232.36 | ⇧ $241.76 |
| Tenet Healthcare (THC) | 88.99% | $90.24 | ⇧ $91.26 |
| NewMarket (NEU) | 88.96% | $636.66 | ⇧ $657.91 |
| Novartis AG (NVS) | 88.94% | $103.11 | ⇧ $104.93 |
| JP Morgan Chase (JPM) | 88.93% | $183.32 | ⇧ $187.73 |
| Comcast Corporation (CMCSA) | 88.91% | $42.07 | ⇧ $43.24 |
| HSBC (HSBC) | 88.89% | $38.37 | ⇧ $38.71 |
| Regeneron Pharmaceuticals (REGN) | 88.6% | $992.36 | ⇧ $1025.52 |
| Procter & Gamble (PG) | 88.57% | $159.36 | ⇧ $163.07 |
| GlaxoSmithKline (GSK) | 88.52% | $42.36 | ⇧ $42.97 |
1. America Movil (AMX)
Shares of America Movil jumped 7.39% in from $18 to $19.33 at 18:21 EST on Tuesday, after five successive sessions in a row of gains. NYSE is rising 0.18% to $17,598.32, following the last session’s downward trend.
América Móvil, S.A.B. de C.V. provides telecommunications services in Latin America and internationally. The company offers wireless and fixed voice services, including airtime, local, domestic, and international long-distance services; and network interconnection services. It also provides data services, such as data centers, data administration, and hosting services to residential and corporate clients; value-added services, including Internet access, messaging and other wireless entertainment, and corporate services; data transmission, email services, instant messaging, content streaming, and interactive applications; and wireless security services, mobile payment solutions, machine-to-machine services, mobile banking, virtual private network services, and video calls and personal communications services. In addition, the company offers residential broadband services; IT solutions to small businesses and large corporations; and cable and satellite television subscriptions. Further, it sells equipment, accessories, and computers; and offers telephone directories, wireless security, call center, advertising, media, and software development services. Additionally, the company provides video, audio, and other media content through the Internet directly from the content provider to the end user. It sells its products and services under the Telcel, Telmex Infinitum, and A1 brands through a network of retailers and service centers to retail customers; and through sales force to corporate customers. América Móvil, S.A.B. de C.V. was incorporated in 2000 and is based in Mexico City, Mexico.
Sales Growth
America Movil’s sales growth is 1.9% for the ongoing quarter and 4.9% for the next.
Revenue Growth
Year-on-year quarterly revenue growth declined by 1%, now sitting on 816.01B for the twelve trailing months.
More news about America Movil.
2. Genmab (GMAB)
Shares of Genmab jumped 2.9% in from $28.27 to $29.09 at 18:21 EST on Tuesday, after three successive sessions in a row of gains. NASDAQ is jumping 0.37% to $16,035.30, after two sequential sessions in a row of losses.
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC. Its products include daratumumab to treat MM, non-MM blood cancers, and AL amyloidosis; GEN1047; tisotumab vedotin for treating cervical, ovarian, and solid cancers; DuoBody-PD-L1x4-1BB, and DuoBody-CD40x4-1BB for treating solid tumors; Epcoritamab for relapsed/refractory diffuse large B-cell lymphoma and chronic lymphocytic leukemia; and HexaBody-CD38 and GEN3017 for treating hematological malignancies. In addition, the company develops Inclacumab, which is in Phase 3 trial for vaso-occlusive crises; Camidanlumab tesirine to treat hodgkin lymphoma and solid tumors; JNJ-64007957 and JNJ-64407564 to treat MM; PRV-015 for treating celiac disease; Mim8 for treating haemophilia A; and Lu AF82422 for treating multiple system atrophy disease. It operates various active pre-clinical programs. The company has a commercial license and collaboration agreement with Seagen Inc. to co-develop tisotumab vedotin. It also has a collaboration agreement with argenx to discover, develop, and commercialize novel therapeutic antibodies with applications in immunology and oncology; and AbbVie for the development of epcoritamab, as well as collaborations with BioNTech, Janssen, and Novo Nordisk A/S. Genmab A/S was founded in 1999 and is headquartered in Copenhagen, Denmark.
Revenue Growth
Year-on-year quarterly revenue growth declined by 8.9%, now sitting on 16.47B for the twelve trailing months.
Sales Growth
Genmab’s sales growth is 43.9% for the ongoing quarter and 17.6% for the next.
More news about Genmab.
3. Orix Corp (IX)
Shares of Orix Corp rose 8.41% in from $96.8 to $104.94 at 18:21 EST on Tuesday, after two sequential sessions in a row of gains. NYSE is jumping 0.18% to $17,598.32, following the last session’s downward trend.
ORIX Corporation provides diversified financial services in Japan, the United States, Asia, Europe, Australasia, and the Middle East. The company's Corporate Financial Services and Maintenance Leasing segment is involved in the finance and fee; leasing and rental of automobiles, electronic measuring instruments, and ICT-related equipment businesses; and provision of life insurance and environment and energy-related products and services. Its Real Estate segment develops, rents, and manages real estate properties; operates facilities; real estate asset management; manages residential condominiums and office building; and provides construction contracting, real estate brokerage, and real estate investment advisory services, as well as operates hotels and Japanese inns. The company's PE Investment and Concession segment engages in the private equity (PE) investment and concession businesses. Its Environment and Energy segment provides renewable energy; ESCO; retails electric power; sells solar panels and battery electricity storage systems; and recycling and waste management services, as well as generates solar power. The company's Insurance segment sells life insurance products through agents, banks, and other financial institutions, as well as face-to-face and online. Its Banking and Credit segment provides banking and consumer finance services. The company's Aircraft and Ships segment engages in the aircraft leasing and management, and ship-related finance and investment businesses. Its ORIX USA segment offers finance, investment, and asset management services. The company's ORIX Europe segment provides equity and fixed income asset management services. Its Asia and Australia segment offers finance and investment businesses. The company was formerly known as Orient Leasing Co., Ltd. and changed its name to ORIX Corporation in 1989. ORIX Corporation was incorporated in 1950 and is headquartered in Tokyo, Japan.
Volatility
Orix Corp’s last week, last month’s, and last quarter’s current intraday variation average was 0.54%, 0.41%, and 0.86%.
Orix Corp’s highest amplitude of average volatility was 0.86% (last week), 0.91% (last month), and 0.86% (last quarter).
Yearly Top and Bottom Value
Orix Corp’s stock is valued at $104.94 at 18:21 EST, higher than its 52-week high of $102.15.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.6%, now sitting on 2.71T for the twelve trailing months.
Moving Average
Orix Corp’s value is way above its 50-day moving average of $95.35 and way higher than its 200-day moving average of $92.02.
More news about Orix Corp.
4. argenx SE (ARGX)
Shares of argenx SE jumped 7.2% in from $384.8 to $412.51 at 18:21 EST on Tuesday, after five consecutive sessions in a row of gains. NASDAQ is jumping 0.37% to $16,035.30, after two successive sessions in a row of losses.
argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany, France, Canada, the United Kingdom, and Italy. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, pemphigus foliaceus, chronic inflammatory demyelinating polyneuropathy, bullous pemphigoid, and idiopathic inflammatory myopathy; and ENHANZE SC. The company is also developing ARGX-109 and ARGX-116; ARGX-117 for severe autoimmune indications; ARGX-118 for airway inflammation; ARGX-119, an antibody that targets muscle-specific tyrosine kinase stage; and ARGX-114, an antibody directed against the mesenchymal-epithelial transition factor receptor. In addition, its partnered product candidates include Cusatuzumab for treatment of acute myeloid leukemia; ARGX-115 for the treatment of cancer; and ARGX-112 to treat interleukin-22 receptor. The company has strategic partnership with AbbVie S.À.R.L., Zai Lab Limited, and LEO Pharma A/S; and collaboration and license agreement with Genor Biopharma Co. Ltd, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., VIB vzw, University of Texas, BioWa, Inc., Staten Biotechnology B.V., and Shire International GmbH. It also has collaboration agreement with Genmab A/S to discover, develop, and commercialize novel therapeutic antibodies with applications in immunology and oncology, as well as a strategic collaboration with IQVIA Holdings Inc. to provide safety systems and services. argenx SE was incorporated in 2008 and is based in Amsterdam, the Netherlands.
Yearly Top and Bottom Value
argenx SE’s stock is valued at $412.51 at 18:21 EST, way under its 52-week high of $550.76 and way above its 52-week low of $327.73.
More news about argenx SE.
5. Abbott Laboratories (ABT)
Shares of Abbott Laboratories jumped 5.18% in from $113.21 to $119.07 at 18:21 EST on Tuesday, following the last session’s downward trend. NYSE is rising 0.18% to $17,598.32, following the last session’s downward trend.
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Moving Average
Abbott Laboratories’s value is above its 50-day moving average of $112.10 and way higher than its 200-day moving average of $105.12.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1.5%, now sitting on 40.11B for the twelve trailing months.
Volatility
Abbott Laboratories’s last week, last month’s, and last quarter’s current intraday variation average was 0.80%, 0.35%, and 0.78%.
Abbott Laboratories’s highest amplitude of average volatility was 0.80% (last week), 0.89% (last month), and 0.78% (last quarter).
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 2.1% and 3.7%, respectively.
More news about Abbott Laboratories.
6. Toll Brothers (TOL)
Shares of Toll Brothers rose by a staggering 12% in from $99.45 to $111.38 at 18:21 EST on Tuesday, after five sequential sessions in a row of gains. NYSE is jumping 0.18% to $17,598.32, following the last session’s downward trend.
Toll Brothers, Inc., together with its subsidiaries, designs, builds, markets, sells, and arranges finance for a range of detached and attached homes in luxury residential communities in the United States. It designs, builds, markets, and sells condominiums through Toll Brothers City Living. The company also develops a range of single-story living and first-floor primary bedroom suite home designs, as well as communities with recreational amenities, such as golf courses, marinas, pool complexes, country clubs, and fitness and recreation centers; and develops, operates, and rents apartments. In addition, it provides various interior fit-out options, such as flooring, wall tile, plumbing, cabinets, fixtures, appliances, lighting, and home-automation and security technologies. Further, the company owns and operates architectural, engineering, mortgage, title, land development, insurance, smart home technology, landscaping, lumber distribution, house component assembly, and component manufacturing operations. It serves luxury first-time, move-up, empty-nester, active-adult, and second-home buyers. Toll Brothers, Inc. was founded in 1967 and is headquartered in Fort Washington, Pennsylvania.
Revenue Growth
Year-on-year quarterly revenue growth declined by 18.6%, now sitting on 9.99B for the twelve trailing months.
Moving Average
Toll Brothers’s worth is way higher than its 50-day moving average of $93.71 and way higher than its 200-day moving average of $78.16.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 4.7% and 4.6%, respectively.
More news about Toll Brothers.
7. Darden Restaurants (DRI)
Shares of Darden Restaurants rose 4.06% in from $163.18 to $169.80 at 18:21 EST on Tuesday, after five consecutive sessions in a row of gains. NYSE is rising 0.18% to $17,598.32, following the last session’s downward trend.
Darden Restaurants, Inc., together with its subsidiaries, owns and operates full-service restaurants in the United States and Canada. It operates under Olive Garden, LongHorn Steakhouse, Cheddar's Scratch Kitchen, Yard House, The Capital Grille, Seasons 52, Bahama Breeze, Eddie V's Prime Seafood, and Capital Burger brand names. Darden Restaurants, Inc. was incorporated in 1995 and is based in Orlando, Florida.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9.7%, now sitting on 11.01B for the twelve trailing months.
Volatility
Darden Restaurants’s last week, last month’s, and last quarter’s current intraday variation average was 0.84%, 0.40%, and 0.89%.
Darden Restaurants’s highest amplitude of average volatility was 0.84% (last week), 1.07% (last month), and 0.89% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Darden Restaurants’s stock is considered to be oversold (<=20).
More news about Darden Restaurants.
8. Astrazeneca (AZN)
Shares of Astrazeneca dropped 1.24% in from $67.16 to $66.33 at 18:21 EST on Tuesday, after two sequential sessions in a row of gains. NYSE is rising 0.18% to $17,598.32, following the last session’s downward trend.
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 30.2% and 25%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.3%, now sitting on 45.81B for the twelve trailing months.
Volatility
Astrazeneca’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.41%, a negative 0.08%, and a positive 0.97%.
Astrazeneca’s highest amplitude of average volatility was 1.41% (last week), 1.37% (last month), and 0.97% (last quarter).
Sales Growth
Astrazeneca’s sales growth is 13.5% for the present quarter and 13.7% for the next.
More news about Astrazeneca.
9. Sherwin (SHW)
Shares of Sherwin rose 7.62% in from $304.62 to $327.83 at 18:21 EST on Tuesday, after five sequential sessions in a row of gains. NYSE is rising 0.18% to $17,598.32, following the last session’s downward trend.
The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group. The Paint Stores Group segment offers architectural paints and coatings, and protective and marine products, as well as OEM product finishes and related products for architectural and industrial paint contractors, and do-it-yourself homeowners. The Consumer Brands Group segment supplies a portfolio of branded and private-label architectural paints, stains, varnishes, industrial products, wood finishes products, wood preservatives, applicators, corrosion inhibitors, aerosols, caulks, and adhesives to retailers, including home centers and hardware stores, and dedicated dealers and distributors. The Performance Coatings Group segment develops and sells industrial coatings for wood finishing and general industrial applications, automotive refinish products, protective and marine coatings, coil coatings, packaging coatings, and performance-based resins and colorants. It serves retailers, dealers, jobbers, licensees, and other third-party distributors through its branches and direct sales staff, as well as through outside sales representatives. The company has operations primarily in the North and South America, the Caribbean, Europe, Asia, and Australia. The Sherwin-Williams Company was founded in 1866 and is headquartered in Cleveland, Ohio.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 4.8% and positive 6.9% for the next.
Moving Average
Sherwin’s worth is way higher than its 50-day moving average of $289.00 and way above its 200-day moving average of $260.38.
More news about Sherwin.
10. Trip.com (TCOM)
Shares of Trip.com jumped by a staggering 19.84% in from $36.9 to $44.22 at 18:21 EST on Tuesday, following the last session’s downward trend. NASDAQ is jumping 0.37% to $16,035.30, after two successive sessions in a row of losses.
Trip.com Group Limited operates as a travel service provider for accommodation reservation, transportation ticketing, packaged tours and in-destination, corporate travel management, and other travel-related services in China and internationally. The company acts as an agent for hotel-related transactions and selling air tickets, as well as provides train, long-distance bus, and ferry tickets; travel insurance products, such as flight delay, air accident, and baggage loss coverage; and air-ticket delivery, online check-in and seat selection, express security screening, real-time flight status tracker, and airport VIP lounge services. It also provides independent leisure travelers bundled packaged-tour products comprising group, semi-group, and customized and packaged tours with various transportation arrangements, including air, cruise, bus, and car rental services. In addition, the company offers integrated transportation and accommodation services; destination transportation and ticket, activity, insurance, visa, and tour guide services; user support, supplier management, and customer relationship management services; and in-destination products and services. Further, it provides its corporate clients with business visit, incentive trip, meeting and conference, travel data collection and analysis, industry benchmark, cost saving analysis, and travel management solutions; and Corporate Travel Management System, an online platform that integrates information management, online booking and authorization, online inquiry, and travel reporting systems. Additionally, the company offers online advertising and financial services. It operates under the Ctrip, Qunar, Trip.com, and Skyscanner brands. The company was formerly known as Ctrip.com International, Ltd. and changed its name to Trip.com Group Limited in October 2019. Trip.com Group Limited was founded in 1999 and is headquartered in Shanghai, the People's Republic of China.
More news about Trip.com.
11. Marriott International (MAR)
Shares of Marriott International rose 2.92% in from $241.72 to $248.78 at 18:21 EST on Tuesday, following the last session’s downward trend. NASDAQ is jumping 0.37% to $16,035.30, after two successive sessions in a row of losses.
Marriott International, Inc. engages in operating, franchising, and licensing hotel, residential, timeshare, and other lodging properties worldwide. It operates its properties under the JW Marriott, The Ritz-Carlton, The Luxury Collection, W Hotels, St. Regis, EDITION, Bvlgari, Marriott Hotels, Sheraton, Westin, Autograph Collection, Renaissance Hotels, Le Méridien, Delta Hotels by Marriott, Tribute Portfolio, Gaylord Hotels, Design Hotels, Marriott Executive Apartments, Apartments by Marriott Bonvoy, Courtyard by Marriott, Fairfield by Marriott, Residence Inn by Marriott, SpringHill Suites by Marriott, Four Points by Sheraton, TownePlace Suites by Marriott, Aloft Hotels, AC Hotels by Marriott, Moxy Hotels, Element Hotels, Protea Hotels by Marriott, and City Express by Marriott brand names, as well as operates residences, timeshares, and yachts. The company was founded in 1927 and is headquartered in Bethesda, Maryland.
Sales Growth
Marriott International’s sales growth is 5.7% for the ongoing quarter and 8.8% for the next.
Volatility
Marriott International’s last week, last month’s, and last quarter’s current intraday variation average was 1.16%, 0.21%, and 1.06%.
Marriott International’s highest amplitude of average volatility was 1.16% (last week), 1.13% (last month), and 1.06% (last quarter).
More news about Marriott International.
12. CRH PLC (CRH)
Shares of CRH PLC jumped by a staggering 11.24% in from $70.54 to $78.47 at 18:21 EST on Tuesday, after four sequential sessions in a row of gains. NYSE is rising 0.18% to $17,598.32, following the last session’s downward trend.
CRH plc, through its subsidiaries, manufactures and distributes building materials in Ireland and internationally. It operates through three segments: Americas Materials, Europe Materials, and Building Products. The company manufactures and supplies cement, lime, aggregates, precast, ready mixed concrete, and asphalt products; concrete masonry and hardscape products comprising pavers, kerbs, retaining walls, and related patio products; It also offers precast concrete and polymer-based products, such as underground vaults, drainage pipes and structures, utility enclosures, and modular precast structures to the water, energy, communication, transportation, and building structures markets; and construction accessories, such as engineered anchoring, fixing, and connection solutions, as well as lifting systems, formwork accessories, and other accessories used in construction applications. In addition, the company offers network access products, which include composite access chambers, covers, passive safety systems, retention sockets, sealants, and meter boxes; and paving and construction services. Further, it provides building and civil engineering contracting, contract surfacing, operates logistics and owned railway infrastructure; sells and distributes cement; and supplies access chambers and ducting products. CRH plc was founded in 1936 and is headquartered in Dublin, Ireland.
Yearly Top and Bottom Value
CRH PLC’s stock is valued at $78.47 at 18:21 EST, under its 52-week high of $79.41 and way above its 52-week low of $46.84.
More news about CRH PLC.
13. Baxter International (BAX)
Shares of Baxter International rose 6.62% in from $39.15 to $41.74 at 18:21 EST on Tuesday, following the last session’s downward trend. NYSE is jumping 0.18% to $17,598.32, following the last session’s downward trend.
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Yearly Top and Bottom Value
Baxter International’s stock is valued at $41.74 at 18:21 EST, way below its 52-week high of $50.21 and way higher than its 52-week low of $31.01.
More news about Baxter International.
14. eBay (EBAY)
Shares of eBay rose 4.76% in from $42.62 to $44.65 at 18:21 EST on Tuesday, after two sequential sessions in a row of losses. NASDAQ is rising 0.37% to $16,035.30, after two successive sessions in a row of losses.
eBay Inc. operates marketplace platforms that connect buyers and sellers in the United States and internationally. The company's marketplace platform includes its online marketplace at ebay.com and the eBay suite of mobile apps. Its platforms enable users to list, buy, and sell various products. The company was founded in 1995 and is headquartered in San Jose, California.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5%, now sitting on 10.06B for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 11.2% and a negative 6.3%, respectively.
More news about eBay.
15. Citizens Financial Group (CFG)
Shares of Citizens Financial Group fell by a staggering 11.22% in from $34.65 to $30.76 at 18:21 EST on Tuesday, following the last session’s downward trend. NYSE is rising 0.18% to $17,598.32, following the last session’s downward trend.
Citizens Financial Group, Inc. operates as the bank holding company that provides retail and commercial banking products and services to individuals, small businesses, middle-market companies, corporations, and institutions in the United States. The company operates in two segments, Consumer Banking and Commercial Banking. The Consumer Banking segment offers deposit products, mortgage and home equity lending products, credit cards, business loans, wealth management, and investment services; and auto, education, and point-of-sale finance loans, as well as digital deposit products. This segment serves its customers through telephone service centers, as well as through its online and mobile platforms. The Commercial Banking segment provides various financial products and solutions, including lending and leasing, deposit and treasury management services, foreign exchange, and interest rate and commodity risk management solutions, as well as syndicated loans, corporate finance, mergers and acquisitions, and debt and equity capital markets services. This segment serves corporate banking, healthcare, technology, asset finance, franchise finance, leasing, asset-based lending, commercial real estate, mid-corporate, and private equity sponsor industries. The company was formerly known as RBS Citizens Financial Group, Inc. and changed its name to Citizens Financial Group, Inc. in April 2014. Citizens Financial Group, Inc. was founded in 1828 and is headquartered in Providence, Rhode Island.
Volatility
Citizens Financial Group’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.23%, a negative 0.71%, and a positive 1.73%.
Citizens Financial Group’s highest amplitude of average volatility was 0.39% (last week), 1.83% (last month), and 1.73% (last quarter).
Moving Average
Citizens Financial Group’s value is under its 50-day moving average of $32.42 and above its 200-day moving average of $28.59.
Yearly Top and Bottom Value
Citizens Financial Group’s stock is valued at $30.76 at 18:21 EST, way below its 52-week high of $42.52 and way above its 52-week low of $22.77.
Revenue Growth
Year-on-year quarterly revenue growth declined by 10.8%, now sitting on 7.54B for the twelve trailing months.
More news about Citizens Financial Group.
16. Kellogg Company (K)
Shares of Kellogg Company jumped 1.33% in from $54.83 to $55.56 at 18:21 EST on Tuesday, after two successive sessions in a row of gains. NYSE is jumping 0.18% to $17,598.32, following the last session’s downward trend.
Kellanova, together with its subsidiaries, manufactures and markets snacks and convenience foods in North America, Europe, Latin America, the Asia Pacific, the Middle East, Australia, and Africa. Its principal products include crackers, crisps, savory snacks, toaster pastries, cereal bars, granola bars and bites, ready-to-eat cereals, frozen waffles, veggie foods, and noodles. The company offers its products under the Kellogg's, Cheez-It, Pringles, Austin, Parati, RXBAR, Eggo, Morningstar Farms, Bisco, Club, Luxe, Minueto, Special K, Toasteds, Town House, Zesta, Zoo Cartoon, Choco Krispis, Crunchy Nut, Kashi, Nutri-Grain, Squares, Zucaritas, Rice Krispies Treats, Sucrilhos, Pop-Tarts, K-Time, Sunibrite, Split Stix, LCMs, Coco Pops, Krave, Frosties, Rice Krispies Squares, Incogmeato, Veggitizers, Gardenburger, Trink, Carr's, Kellogg's Extra, Müsli, Fruit ‘n Fibre, Kellogg's Crunchy Nut, Country Store, Smacks, Honey Bsss, Zimmy's, Toppas, Tresor, Froot Ring, Chocos, Chex, Guardian, Just Right, Sultana Bran, Rice Bubbles, Sustain, and Choco Krispies brand names. It sells its products to retailers through direct sales forces, as well as brokers and distributors. The company was formerly known as Kellogg Company and changed its name to Kellanova in October 2023. Kellanova was founded in 1906 and is headquartered in Chicago, Illinois.
Moving Average
Kellogg Company’s value is higher than its 50-day moving average of $54.81 and below its 200-day moving average of $57.32.
More news about Kellogg Company.
17. Hormel Foods (HRL)
Shares of Hormel Foods jumped 0.78% in from $30.68 to $30.92 at 18:21 EST on Tuesday, after two sequential sessions in a row of losses. NYSE is rising 0.18% to $17,598.32, following the last session’s downward trend.
Hormel Foods Corporation develops, processes, and distributes various meat, nuts, and other food products to retail, foodservice, deli, and commercial customers in the United States and internationally. It operates through three segments: Retail, Foodservice, and International segments. The company provides various perishable products that include fresh meats, frozen items, refrigerated meal solutions, sausages, hams, guacamoles, and bacons; and shelf-stable products comprising canned luncheon meats, nut butters, snack nuts, chili, shelf-stable microwaveable meals, hash, stews, tortillas, salsas, tortilla chips, nutritional food supplements, and others. It sells its products under the HORMEL, ALWAYS TENDER, APPLEGATE, AUSTIN BLUES, BACON 1, BLACK LABEL, BREAD READY, BURKE, CAFÉ H, CERATTI, CHI-CHI'S, COLUMBUS, COMPLEATS, CORN NUTS, CURE 81, DAN'S PRIZE, DI LUSSO, DINTY MOORE, DON MIGUEL, DOÑA MARIA, EMBASA, FAST ‘N EASY, FIRE BRAISED, FONTANINI, HAPPY LITTLE PLANTS, HERDEZ, HORMEL GATHERINGS, HORMEL SQUARE TABLE, HORMEL VITAL CUISINE, HOUSE OF TSANG, JENNIE-O, JUSTIN'S, LA VICTORIA, LAYOUT, LLOYD'S, MARY KITCHEN, MR. PEANUT, NATURAL CHOICE, NUT-RITION, OLD SMOKEHOUSE, OVEN READY, PILLOW PACK, PLANTERS, ROSA GRANDE, SADLER'S SMOKEHOUSE, SKIPPY, SPAM, SPECIAL RECIPE, THICK & EASY, VALLEY FRESH, AND WHOLLY brands through sales personnel, independent brokers, and distributors. The company was formerly known as Geo. A. Hormel & Company and changed its name to Hormel Foods Corporation in January 1995. Hormel Foods Corporation was founded in 1891 and is headquartered in Austin, Minnesota.
Moving Average
Hormel Foods’s worth is below its 50-day moving average of $31.07 and way under its 200-day moving average of $35.98.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Hormel Foods’s stock is considered to be oversold (<=20).
More news about Hormel Foods.
18. Air Products and Chemicals (APD)
Shares of Air Products and Chemicals fell by a staggering 12.25% in from $264.8 to $232.36 at 18:21 EST on Tuesday, following the last session’s downward trend. NYSE is rising 0.18% to $17,598.32, following the last session’s downward trend.
Air Products and Chemicals, Inc. provides atmospheric gases, process and specialty gases, equipment, and related services in the Americas, Asia, Europe, the Middle East, India, and internationally. The company produces atmospheric gases, including oxygen, nitrogen, and argon; process gases, such as hydrogen, helium, carbon dioxide, carbon monoxide, and syngas; and specialty gases for customers in various industries, including refining, chemical, manufacturing, electronics, energy production, medical, food, and metals. It also designs and manufactures equipment for air separation, hydrocarbon recovery and purification, natural gas liquefaction, and liquid helium and liquid hydrogen transport and storage. The company was founded in 1940 and is headquartered in Allentown, Pennsylvania.
Volatility
Air Products and Chemicals’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.03%, a negative 0.61%, and a positive 1.18%.
Air Products and Chemicals’s highest amplitude of average volatility was 1.03% (last week), 2.04% (last month), and 1.18% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Air Products and Chemicals’s stock is considered to be oversold (<=20).
Yearly Top and Bottom Value
Air Products and Chemicals’s stock is valued at $232.36 at 18:21 EST, way under its 52-week high of $307.71 and above its 52-week low of $212.24.
More news about Air Products and Chemicals.
19. Tenet Healthcare (THC)
Shares of Tenet Healthcare rose 8.58% in from $83.11 to $90.24 at 18:21 EST on Tuesday, following the last session’s downward trend. NYSE is rising 0.18% to $17,598.32, following the last session’s downward trend.
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services, such as orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. It operates hospitals, ambulatory surgery centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Tenet Healthcare’s stock is considered to be oversold (<=20).
Moving Average
Tenet Healthcare’s worth is way above its 50-day moving average of $70.89 and way higher than its 200-day moving average of $70.42.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5.5%, now sitting on 20.16B for the twelve trailing months.
More news about Tenet Healthcare.
20. NewMarket (NEU)
Shares of NewMarket rose by a staggering 13.55% in from $560.69 to $636.66 at 18:21 EST on Tuesday, following the last session’s downward trend. NYSE is rising 0.18% to $17,598.32, following the last session’s downward trend.
NewMarket Corporation, through its subsidiaries, primarily engages in the manufacture and sale of petroleum additives. The company offers lubricant additives for use in various vehicle and industrial applications, including engine oils, transmission fluids, off-road powertrain and hydraulic systems, gear oils, hydraulic oils, turbine oils, and other applications where metal-to-metal moving parts are utilized; engine oil additives designed for passenger cars, motorcycles, on and off-road heavy duty commercial equipment, locomotives, and engines in ocean-going vessels; driveline additives designed for products, such as transmission fluids, axle fluids, and off-road powertrain fluids; and industrial additives designed for products for industrial applications consisting of hydraulic fluids, grease, industrial gear fluids, and industrial specialty applications, such as turbine oils. It also provides fuel additives that are used to enhance the oil refining process and the performance of gasoline, diesel, biofuels, and other fuels to industry, government, original equipment manufacturers, and individual customers. In addition, the company engages in the marketing of antiknock compounds, as well as contracted manufacturing and services activities; and owns and manages a real property in Virginia. It operates in North America, Latin America, Asia Pacific, Europe, the Middle East, Africa, and India. NewMarket Corporation was founded in 1887 and is headquartered in Richmond, Virginia.
Sales Growth
NewMarket’s sales growth for the next quarter is 2.9%.
Volatility
NewMarket’s last week, last month’s, and last quarter’s current intraday variation average was 1.23%, 0.56%, and 0.99%.
NewMarket’s highest amplitude of average volatility was 1.23% (last week), 1.23% (last month), and 0.99% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NewMarket’s stock is considered to be oversold (<=20).
More news about NewMarket.
21. Novartis AG (NVS)
Shares of Novartis AG slid 4.62% in from $108.1 to $103.11 at 18:21 EST on Tuesday, following the last session’s downward trend. NYSE is rising 0.18% to $17,598.32, following the last session’s downward trend.
Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. It offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.
Sales Growth
Novartis AG’s sales growth is negative 9.2% for the present quarter and negative 12% for the next.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 2.9% and 1.6%, respectively.
More news about Novartis AG.
22. JP Morgan Chase (JPM)
Shares of JP Morgan Chase jumped 6.22% in from $172.59 to $183.32 at 18:21 EST on Tuesday, following the last session’s downward trend. NYSE is jumping 0.18% to $17,598.32, following the last session’s downward trend.
JPMorgan Chase & Co. operates as a financial services company worldwide. It operates through four segments: Consumer & Community Banking (CCB), Corporate & Investment Bank (CIB), Commercial Banking (CB), and Asset & Wealth Management (AWM). The CCB segment offers deposit, investment and lending products, cash management, and payments and services; mortgage origination and servicing activities; residential mortgages and home equity loans; and credit cards, auto loans, leases, and travel services to consumers and small businesses through bank branches, ATMs, and digital and telephone banking. The CIB segment provides investment banking products and services, including corporate strategy and structure advisory, and equity and debt market capital-raising services, as well as loan origination and syndication; payments; and cash and derivative instruments, risk management solutions, prime brokerage, and research. This segment also offers securities services, including custody, fund accounting and administration, and securities lending products for asset managers, insurance companies, and public and private investment funds. The CB segment provides financial solutions, including lending, payments, investment banking, and asset management to small and midsized companies, local governments, nonprofit clients, and large corporations, as well as investors, developers, and owners of multifamily, office, retail, industrial, and affordable housing properties. The AWM segment offers multi-asset investment management solutions in equities, fixed income, alternatives, and money market funds to institutional clients and retail investors; and retirement products and services, brokerage, custody, estate planning, lending, deposits, and investment management products to high net worth clients. JPMorgan Chase & Co. was founded in 1799 and is headquartered in New York, New York.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 3.7% and a negative 20%, respectively.
Yearly Top and Bottom Value
JP Morgan Chase’s stock is valued at $183.32 at 18:21 EST, under its 52-week high of $185.20 and way higher than its 52-week low of $123.11.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.1%, now sitting on 146.01B for the twelve trailing months.
Sales Growth
JP Morgan Chase’s sales growth is negative 1.4% for the current quarter and negative 10.5% for the next.
More news about JP Morgan Chase.
23. Comcast Corporation (CMCSA)
Shares of Comcast Corporation fell 9.6% in from $46.54 to $42.07 at 18:21 EST on Tuesday, following the last session’s upward trend. NASDAQ is rising 0.37% to $16,035.30, after two consecutive sessions in a row of losses.
Comcast Corporation operates as a media and technology company worldwide. It operates through Residential Connectivity & Platforms, Business Services Connectivity, Media, Studios, and Theme Parks segments. The Residential Connectivity & Platforms segment provides residential broadband and wireless connectivity services, residential and business video services, sky-branded entertainment television networks, and advertising. The Business Services Connectivity segment offers connectivity services for small business locations, which include broadband, wireline voice, and wireless services, as well as solutions for medium-sized customers and larger enterprises; and small business connectivity services in the United Kingdom. The Media segment operates NBCUniversal's television and streaming business, including national and regional cable networks; the NBC and Telemundo broadcast networks and owned local broadcast television stations; and Peacock, a direct-to-consumer streaming services. It also operates international television networks comprising the Sky Sports networks, as well as other digital properties. The Studios segment operates NBCUniversal and Sky film and television studio production and distribution operations. The Theme Parks segment operates Universal theme parks in Orlando, Florida; Hollywood, California; Osaka, Japan; and Beijing, China. The company also offers a consolidated streaming platforms under the Philadelphia Flyers and the Wells Fargo Center arena in Philadelphia, Pennsylvania; and Xumo. Comcast Corporation was founded in 1963 and is headquartered in Philadelphia, Pennsylvania.
Revenue Growth
Year-on-year quarterly revenue growth grew by 2.3%, now sitting on 121.57B for the twelve trailing months.
Sales Growth
Comcast Corporation’s sales growth is negative 5.7% for the current quarter and negative 6.5% for the next.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Comcast Corporation’s stock is considered to be oversold (<=20).
More news about Comcast Corporation.
24. HSBC (HSBC)
Shares of HSBC slid 3.15% in from $39.62 to $38.37 at 18:21 EST on Tuesday, after two successive sessions in a row of losses. NYSE is jumping 0.18% to $17,598.32, following the last session’s downward trend.
HSBC Holdings plc provides banking and financial services worldwide. The company operates through Wealth and Personal Banking, Commercial Banking, and Global Banking and Markets segments. The Wealth and Personal Banking segment offers retail banking and wealth products, including current and savings accounts, mortgages and personal loans, credit and debit cards, and local and international payment services; and wealth management services comprising insurance and investment products, global asset management services, investment management, and private wealth solutions. This segment serves personal banking and high net worth individuals. The Commercial Banking segment provides credit and lending, treasury management, payment, cash management, commercial insurance, and investment services; commercial cards; international trade and receivables finance services; foreign exchange products; capital raising services on debt and equity markets; and advisory services. It serves small and medium sized enterprises, mid-market enterprises, and corporates. The Global Banking and Markets segment offers financing, advisory, and transaction services; and credit, rates, foreign exchange, equities, money markets, and securities services; and engages in principal investment activities. It serves government, corporate and institutional clients, and private investors. HSBC Holdings plc was founded in 1865 and is headquartered in London, the United Kingdom.
More news about HSBC.
25. Regeneron Pharmaceuticals (REGN)
Shares of Regeneron Pharmaceuticals jumped 4.22% in from $952.18 to $992.36 at 18:21 EST on Tuesday, after four successive sessions in a row of gains. NASDAQ is jumping 0.37% to $16,035.30, after two successive sessions in a row of losses.
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.
Sales Growth
Regeneron Pharmaceuticals’s sales growth for the current quarter is 8.1%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 0.7% and positive 8% for the next.
More news about Regeneron Pharmaceuticals.
26. Procter & Gamble (PG)
Shares of Procter & Gamble jumped 2.07% in from $156.13 to $159.36 at 18:21 EST on Tuesday, following the last session’s downward trend. NYSE is jumping 0.18% to $17,598.32, following the last session’s downward trend.
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands. The Grooming segment provides shave care products and appliances under the Braun, Gillette, and Venus brand names. The Health Care segment offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brand names; and gastrointestinal, rapid diagnostics, respiratory, vitamins/minerals/supplements, pain relief, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. The Fabric & Home Care segment provides fabric enhancers, laundry additives, and laundry detergents under the Ariel, Downy, Gain, and Tide brands; and air care, dish care, P&G professional, and surface care products under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. The Baby, Feminine & Family Care segment offers baby wipes, taped diapers, and pants under the Luvs and Pampers brands; adult incontinence and feminine care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. The company sells its products primarily through mass merchandisers, e-commerce, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores, high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.
Moving Average
Procter & Gamble’s worth is above its 50-day moving average of $152.01 and above its 200-day moving average of $150.85.
Volatility
Procter & Gamble’s last week, last month’s, and last quarter’s current intraday variation average was 0.53%, 0.18%, and 0.74%.
Procter & Gamble’s highest amplitude of average volatility was 0.53% (last week), 0.47% (last month), and 0.74% (last quarter).
Revenue Growth
Year-on-year quarterly revenue growth grew by 3.2%, now sitting on 83.93B for the twelve trailing months.
Sales Growth
Procter & Gamble’s sales growth for the next quarter is negative 5.8%.
More news about Procter & Gamble.
27. GlaxoSmithKline (GSK)
Shares of GlaxoSmithKline jumped 8.45% in from $39.06 to $42.36 at 18:21 EST on Tuesday, after three consecutive sessions in a row of gains. NYSE is rising 0.18% to $17,598.32, following the last session’s downward trend.
GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9.2%, now sitting on 30.33B for the twelve trailing months.
Yearly Top and Bottom Value
GlaxoSmithKline’s stock is valued at $42.36 at 18:21 EST, below its 52-week high of $42.61 and way above its 52-week low of $33.20.
Moving Average
GlaxoSmithKline’s value is higher than its 50-day moving average of $39.40 and way above its 200-day moving average of $36.46.
More news about GlaxoSmithKline.
